NIH-funded research R01 grant

Proteomic signatures linking delirium, aging, and Alzheimer's risk

Official title: AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline

Funded at Beth Israel Deaconess Medical Center · NIH-11238069 · Data updated 2026-11-12

The team looks for blood protein patterns that predict which older adults may get sudden confusion after surgery and which people later have lasting memory decline or dementia.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 1, 2015
Project endNovember 30, 2027
Funding year2026
Award (this year)$846,502
NIH project number5R01AG051658-08
Project IDNIH-11238069 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are older adults scheduled for major elective surgery who can give blood before and after surgery and agree to follow-up cognitive testing.

Less likely to help

Younger people, those not undergoing surgery, or individuals whose cognitive problems have non-AD causes would be unlikely to benefit directly from this work.

What this research studies

From the patient's point of view, researchers will use blood samples taken before and after elective surgery to compare people who do and do not develop delirium. They will measure many proteins (a proteomics approach) and connect those patterns to markers of biological aging and Alzheimer's disease risk. The work builds on prior SAGES studies that found inflammation and neuronal-injury proteins linked to delirium. The goal is to find pre-surgery signals that identify patients at higher risk and to understand how delirium relates to longer-term cognitive decline.

Why it matters

Potential benefit: If successful, this could let clinicians identify older surgical patients at high risk for delirium and later memory problems so they can try preventive care or targeted treatments.

How similar studies have gone: Earlier SAGES work has already found and validated protein signatures linked to delirium, so this project builds on promising prior findings rather than starting from scratch.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Marcantonio, Edward R — Beth Israel Deaconess Medical Center
  • Study coordinator: Marcantonio, Edward R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.